Metastatic Cancer Clinical Trials

A listing of Metastatic Cancer medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 17 clinical trials
Featured trial
Sanofi H1N1 + TIV - Adults and Elderly-TrialX Check  

Welcome to the Media Showcase PageIn this page, we will showcase a sample image and a video. Below you will find an example of how you can easily embed multimedia content along with descriptive text.Example ImageThis is an example of an image embedded into a webpage. Images can be used …

Accepts healthy volunteers
  • 0 views
  • 08 May, 2025
  • 7 locations
Featured trial
Digital Intervention for Psychedelic Preparation (DIPP): Comparing Meditation and Music-Based Programs ((DIPP-RCFT))

(recruitment rates and participant retention) and intervention adherence (completion rates of DIPP program activities). Secondary outcomes include participant ratings of the platform's feasibility, acceptability

Accepts healthy volunteers
  • 0 views
  • 10 Feb, 2025
  • 1 location
Featured trial
Elective Adhesiolysis vs. a Wait-and-see Policy to Prevent Recurrences After Conservative Treatment of Adhesive Small Bowel Obstruction (AWARE)  

recurrence, defined as readmission for obstructive systems with aetiology of adhesions confirmed by CT. The investigators hypothesize a 50% reduction in recurrence in the intervention arm. Secondary outcomes

  • 0 views
  • 27 Feb, 2025
  • 2 locations
Featured trial
Selinexor, Carfilzomib, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma (SINE)

This phase I trial studies the side effects and best dose of selinexor and carfilzomib when given together with dexamethasone in treating patients with multiple myeloma that has returned or does not respond to treatment. Drugs used in chemotherapy, such as selinexor and dexamethasone, work in different ways to stop …

  • 0 views
  • 06 May, 2025
  • 1 location
Immunogenicity and Safety Study of a Quadrivalent Meningococcal Conjugate Vaccine When Co-administered With Routine Pediatric Vaccines in Healthy Infants and Toddlers in Europe

, tetanus, pertussis, hepatitis B, poliomyelitis and Haemophilus influenzae type b [DTaP-IPV-HB-Hib vaccine]) to infants and toddlers 6 weeks to 18 months oldSecondary objectives are:To

Accepts healthy volunteers
  • 0 views
  • 06 Feb, 2025
  • 1 location
A Study to Evaluate the Efficacy, Safety, and Tolerability of IMVT-1402 in Adult Participants With Active, Difficult to Treat Rheumatoid Arthritis

This Phase 2b, multicenter, double-blind, placebo-controlled, randomized withdrawal study is designed to assess the efficacy and safety of IMVT-1402 in adult participants with active, difficult-to-treat, anti-citrullinated protein autoantibody (ACPA) positive rheumatoid arthritis (RA). The primary objective is to evaluate the effects of IMVT-1402 compared to placebo, as measured by the …

  • 0 views
  • 13 Feb, 2025
  • 2 locations
A Study to Investigate Long-term Safety and Tolerability of Tolebrutinib in Participants With Multiple Sclerosis.

This is a Phase 3 extension, global, multicenter study to assess the long-term safety and tolerability of tolebrutinib in adult participants (aged ≥18 years) with RMS, PPMS, or NRSPMS who were previously enrolled in the Phase 2b LTS (LTS16004) or 1 of the 4 Phase 3 tolebrutinib pivotal trials (GEMINI …

  • 0 views
  • 06 Feb, 2025
  • 13 locations
A Study to Investigate Long-term Safety and Tolerability of Itepekimab in Participants With COPD (AERIFY-4)

period of the clinical studies EFC16750 or EFC16819. A secondary purpose of this study is to provide efficacy outcomes beyond the treatment period of the parent trials EFC16750 and EFC16819. Study

  • 0 views
  • 06 Feb, 2025
  • 79 locations
A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy (OrigAMI-3)

or metastatic colorectal cancer who have previously received chemotherapy.

  • 0 views
  • 13 Feb, 2025
  • 54 locations
Teplizumab in Pediatric Stage 2 Type 1 Diabetes (PETITE-T1D)

The purpose of this study is to assess the safety and pharmacokinetics (PK) of teplizumab in participants with Stage 2 type 1 diabetes who are <8 years of age.

  • 0 views
  • 06 Feb, 2025
  • 10 locations